Nathaniel Erdmann

Statistics

Publications

Citations

2.8K

H-Index

Active since

2018

Affiliations

University of Alabama at Birmingham(Current)

Massachusetts General Hospital

Brigham and Women's Hospital

Harvard University

University of California, San Francisco

Nathaniel Erdmann is an author at University of Alabama at Birmingham specializing in infectious diseases, sars-cov-2 infection, and antiviral immunity.

Publications per year

2018–2025

Publications

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

André C. Kalil, Thomas F. Patterson, Aneesh K. Mehta et al. · New England Journal of Medicine · 2020 · 1.9K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson et al. · The Lancet Respiratory Medicine · 2022 · 128 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +3

Sex Differences in Long COVID

Dimpy P. Shah, Tanayott Thaweethai, Elizabeth W. Karlson et al. · JAMA Network Open · 2025 · 95 citations · Full text

Public Health, Infectious Diseases, Population Health Sciences +14

COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation

Michael J. Patton, Carlos J. Orihuela, Kevin S. Harrod et al. · Critical Care · 2023 · 93 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +14

Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters

Michael S. Piepenbrink, Jun‐Gyu Park, Fatai S. Oladunni et al. · Cell Reports Medicine · 2021 · 73 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

1–5 of 22